PEAK6 Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$135K Buy
+6,400
New +$121K ﹤0.01% 3563
2017
Q4
Sell
-30,800
Closed -$548K 4278
2017
Q3
$548K Buy
30,800
+16,200
+111% +$334K ﹤0.01% 2485
2017
Q2
$370K Buy
+14,600
New +$351K ﹤0.01% 2801

Other funds holding EVH

PEAK6 Group's EVH Position: Q2 2018 in Review

PEAK6 Group reduced its Evolent Health (EVH) stake by 27% in Q2 2018, selling an estimated $110K and leaving 15,903 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

PEAK6 Group first reported a position in EVH in Q1 2017 and has held it in 5 quarters since. The position peaked at $1.16M in Q2 2017. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

  • PEAK6 Group held 15,903 shares of Evolent Health worth $335K as of Q2 2018.
  • PEAK6 Group sold 5,787 Evolent Health shares in Q2 2018, an estimated $110K.
  • Evolent Health made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2920 holding.
  • PEAK6 Group first reported a position in Evolent Health in Q1 2017 and has held it in 5 quarters since.
  • PEAK6 Group's Evolent Health position peaked at $1.16M in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.